Waterdrop Inc. to Report First Quarter 2026 Financial Results on June 16, 2026by krapalmJune 4, 2026PR Newswire
Robo.ai Subsidiary Neurovia AI to Participate as Official Government Al Cybersecurity Partner at The 3rd Government Cybersecurity Summitby krapalmJune 4, 2026PR Newswire
Robo.ai Subsidiary Neurovia AI to Participate as Official Government AI Cybersecurity Partner at The 3rd Government Cybersecurity Summitby krapalmJune 4, 2026PR Newswire
Everest Medicines Enters Commercialization License Agreement with Mabworks for Bejescin® in the Asia-Pacific Marketby krapalmJune 4, 2026PR Newswire
GAC Posts 140% Export Growth in May, Advancing Its Vision of Sustainable Global Mobilityby krapalmJune 4, 2026PR Newswire
ASTROS Hosts “ASTROS Wireless Day 2026” to Showcase AI-Powered Wireless Collaboration and Smart Workspace Applicationsby krapalmJune 4, 2026PR Newswire
Cheetah Mobile To Report First Quarter 2026 Financial Results on June 10, 2026by krapalmJune 4, 2026PR Newswire
Delta Thailand Showcases Integrated Building Automation Solutions for Smarter, Healthier and More Sustainable Spaces at NOVA Expo 2026by krapalmJune 4, 2026PR Newswire
TWSE and Industry Partners Highlight Taiwan’s Central Role in the Global AI and Semiconductor Race at COMPUTEX 2026by krapalmJune 4, 2026PR Newswire
CHEVRON APARTMENTS PTY LTD ANNOUNCES OFFERING OF AUD 4,045,913 SENIOR SECURED LOAN NOTE OFFERby krapalmJune 4, 2026PR Newswire
Shoplazza Helps Australian Merchants Turn Product Ideas Into Ready-to-Sell Online Stores With AIby krapalmJune 4, 2026PR Newswire
HYXI เปิดตัวระบบจัดการพลังงานอัตโนมัติแบบ AI-Native ที่งาน SNEC 2026by krapalmJune 4, 2026PR Newswire
TelkomMetra Strengthens Its Business Portfolio Restructuring Strategy, AdMedika Group Ready for Distinct Expansion under Fullerton Healthby krapalmJune 4, 2026PR Newswire
Lupeng Pharmaceutical’s Fourth-Generation BTK Inhibitor Rocbrutinib Approved in China for Relapsed or Refractory Mantle Cell Lymphomaby krapalmJune 4, 2026PR Newswire
PaidBy® by Xryma Plc, partners with Mastercard to scale cross-border account-to-account paymentsby krapalmJune 4, 2026PR Newswire
World’s First CLDN18.2 ADC for Regulatory Review: Innovent Biologics Announces IBI343 (arcotatug tavatecan) Met Primary Endpoint in International Phase 3 Study in Advanced Refractory Gastric Cancer and NDA Accepted by China NMPAby krapalmJune 4, 2026PR Newswire
AIDIMM™ & AILPBGA™ Make Global Debut | Longsys Spotlights Full-Stack Edge AI Storage Solutions at COMPUTEX 2026by krapalmJune 4, 2026PR Newswire
